ADCs, Chemotherapy, and Checkpoint Blockade in Urothelial Carcinoma

Jonathan E. Rosenberg MD is the Chief of the Genitourinary Oncology Service at the Memorial Sloan Kettering Cancer Center (MSKCC), Attending Physician at Memorial Hospital at MSKCC, and Professor of Medicine at Weill Cornell Medical College. He holds the Enno W. Ercklentz Chair in Genitourinary Oncology.Dr. Rosenberg received his undergraduate degree from Duke University and his medical degree from Harvard Medical School. Dr. Rosenberg completed his internship and residency in internal medicine at New York Presbyterian Hospital-Cornell Medical Center and Hematology/Oncology Fellowship at UCSF. He had previously served on the faculty at UCSF Comprehensive Cancer Center and the Dana-Farber Cancer Institute prior to coming to MSKCC. Dr. Rosenberg’s research focuses on understanding bladder cancer biology with the goal of developing new therapeutic approaches in bladder cancer. He works closely with laboratory investigators to correlate novel genetic biomarkers with clinical outcomes in bladder cancer.